Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 1Pleural Effusion, Malignant 1Pancreatic Neoplasms 1Neoplasms, Plasma Cell 1Multiple Myeloma 1Mesothelioma, Malignant 1Leukemia, Myeloid, Chronic-Phase 1Immunoglobulin Light-chain Amyloidosis 1Glioblastoma 1Carcinoma, Hepatocellular 1Anxiety Disorders 1

Interventions

Metformin 9Inositol 5Letrozole 4Surveys and Questionnaires 3Clomiphene 3semaglutide 1mirabegron 1maltodextrin 1dapagliflozin 1Tamoxifen 1Sodium-Glucose Transporter 2 Inhibitors 1Sex Characteristics 1Positron-Emission Tomography 1Pioglitazone 1Pharmaceutical Preparations 1Liraglutide 1Hydroquinones 1Diet, Mediterranean 1Diet, Ketogenic 1Contraceptives, Oral 1Calibration 1Ascorbic Acid 1Acupuncture Therapy 15-methyltetrahydrofolate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Polycystic Ovary Syndrome × Pharmaceutical Preparations × 90 days × Clear all
NCT06813118 2026-05-07

Comparison of Clomid and Lezra With Lezra for Ovulation Induction in Clomid Resistant PCOS Case

HITEC-Institute of Medical Sciences

Phase 1 Completed
42 enrolled

Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡